{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:07:17Z","timestamp":1779433637072,"version":"3.53.1"},"reference-count":11,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Background:<\/jats:title>\n Tenecteplase (TNK) is a novel thrombolytic agent with improved fibrin specificity and longer half-life than alteplase. It is increasingly being adopted worldwide for the treatment of acute ischemic stroke (AIS). Although well tolerated, rare adverse reactions can occur, such as angioedema, which can rapidly progress and potentially cause airway compromise.<\/jats:p>\n <\/jats:sec>\n \n Case Description:<\/jats:title>\n We report a 60-year-old female presenting to the neurology emergency department with acute right-sided hemiplegia and motor aphasia who received intravenous TNK approximately 2 h after symptom onset. Shortly after admission, she developed progressive oropharyngeal angioedema accompanied by urticaria and inspiratory stridor. Given the risk of impending airway obstruction, she required urgent airway management with endotracheal intubation and initiation of mechanical ventilation. After stabilization, she underwent subsequent mechanical thrombectomy and carotid stenting, which were successful.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Early recognition of thrombolytic-associated angioedema and immediate involvement of a multidisciplinary team are critical for airway protection and continuation of reperfusion therapies, helping to optimize clinical outcomes in AIS.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/sni_177_2026","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:30:09Z","timestamp":1779431409000},"page":"307","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angioedema as anaphylactic reaction following tenecteplase administration in acute ischemic stroke: A case report"],"prefix":"10.25259","volume":"17","author":[{"given":"Ur\u0161ka","family":"\u010cepin","sequence":"first","affiliation":[{"name":"Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"O\u017eek","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Treb\u0161e","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina \u0160urlan","family":"Popovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Zupan","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senta","family":"Frol","sequence":"additional","affiliation":[{"name":"Department of Vascular Neurology, University Medical Center, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"10.25259\/SNI_177_2026\/ref-1","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.25259\/SNI_177_2026\/ref-2","first-page":"3257215","article-title":"Angioedema secondary to IV tissue plasminogen activator administration for treatment of acute ischemic stroke","volume":"2018","author":"Chaucer","year":"2018","journal-title":"Case Rep Crit Care"},{"key":"10.25259\/SNI_177_2026\/ref-3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00415-005-0789-9","article-title":"Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke","volume":"252","author":"Engelter","year":"2005","journal-title":"J Neurol"},{"key":"10.25259\/SNI_177_2026\/ref-4","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/STROKEAHA.119.025260","article-title":"Angioedema in stroke patients with thrombolysis","volume":"50","author":"Fr\u00f6hlich","year":"2019","journal-title":"Stroke"},{"key":"10.25259\/SNI_177_2026\/ref-5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s12028-012-9678-0","article-title":"Angioedema after tPA: What neurointensivists should know","volume":"16","author":"Fugate","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.25259\/SNI_177_2026\/ref-6","first-page":"1281","article-title":"Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke","volume":"162","author":"Hill","year":"2000","journal-title":"CMAJ"},{"key":"10.25259\/SNI_177_2026\/ref-7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1212\/01.WNL.0000058840.66596.1A","article-title":"Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke","volume":"60","author":"Hill","year":"2003","journal-title":"Neurology"},{"key":"10.25259\/SNI_177_2026\/ref-8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jnnp-2014-308097","article-title":"Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke","volume":"86","author":"Hurford","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.25259\/SNI_177_2026\/ref-9","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1161\/STROKEAHA.124.047060","article-title":"Angioedema after use of recombinant tissue-type plasminogen activators in stroke","volume":"55","author":"Hutten","year":"2024","journal-title":"Stroke"},{"key":"10.25259\/SNI_177_2026\/ref-10","article-title":"Anaphylaxis","volume-title":"StatPearls","author":"McLendon","year":"2025"},{"key":"10.25259\/SNI_177_2026\/ref-11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/joim.12962","article-title":"Angioedema associated with thrombolysis for ischemic stroke: Analysis of a case-control study","volume":"286","author":"Vigneron","year":"2019","journal-title":"J Intern Med"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/angioedema-as-anaphylactic-reaction-following-tenecteplase-administration-in-acute-ischemic-stroke-a-case-report\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/angioedema-as-anaphylactic-reaction-following-tenecteplase-administration-in-acute-ischemic-stroke-a-case-report\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:30:12Z","timestamp":1779431412000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/angioedema-as-anaphylactic-reaction-following-tenecteplase-administration-in-acute-ischemic-stroke-a-case-report\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":11,"alternative-id":["10.25259\/SNI_177_2026"],"URL":"https:\/\/doi.org\/10.25259\/sni_177_2026","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"307"}}